Genotyping of infectious bronchitis virus in Canada.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Ojkic D;Ojkic D; Susta L; Susta L; Martin E; Martin E
  • Source:
    Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc [J Vet Diagn Invest] 2024 Nov; Vol. 36 (6), pp. 804-808. Date of Electronic Publication: 2024 Aug 06.
  • Publication Type:
    Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Sage Country of Publication: United States NLM ID: 9011490 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1943-4936 (Electronic) Linking ISSN: 10406387 NLM ISO Abbreviation: J Vet Diagn Invest Subsets: MEDLINE
    • Publication Information:
      Publication: 2011-: Thousand Oaks, CA : Sage
      Original Publication: 1989-2004 : Columbia, MO : American Association of Veterinary Laboratory Diagnosticians
    • Subject Terms:
    • Abstract:
      From 2014-2023, infectious bronchitis virus (IBV) was detected in 6,589 samples from Canada, and partial nucleotide (nt) sequences of the IBV spike protein ( S ) gene were determined for 1,678 samples. Based on their S gene nt sequence identities and origin, Canadian IBVs could be classified into 4 groups: 1) 50.3% were variant viruses related to strains described in the United States; 2) 45.6% were vaccine-like viruses; 3) 2.1% were Eurasian viruses; 4) 2.0% were Canadian variants. Outbreaks with IBVs related to strains CAL1734/04, 4/91, and DMV/1639/11 were often associated with more severe disease in all chicken commodity groups. With the emergence of numerous IBV strains, the severity of infection and number of affected flocks increased. Outbreaks with various IBV strains overlapped in their emergence, peaked, and regressed, but the introduction of DMV/1639/11 has resulted in a continuous field challenge since its first detection in 2015.
      Competing Interests: Declaration of conflicting interestsWe declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
    • References:
      Avian Dis. 2002 Oct-Dec;46(4):847-58. (PMID: 12495045)
      Dev Comp Immunol. 2000 Mar-Apr;24(2-3):187-200. (PMID: 10717287)
      Avian Dis. 2022 Mar;66(1):112-118. (PMID: 35191651)
      Vet Rec. 1996 Feb 24;138(8):178-80. (PMID: 8677618)
      Vaccines (Basel). 2022 Jul 27;10(8):. (PMID: 36016082)
      Avian Pathol. 2014;43(3):264-8. (PMID: 24754612)
      Avian Dis. 2013 Mar;57(1):65-70. (PMID: 23678731)
      Avian Dis. 2007 Jun;51(2):527-33. (PMID: 17626478)
      Infect Genet Evol. 2016 Apr;39:349-364. (PMID: 26883378)
      Can J Vet Res. 2008 Oct;72(5):403-10. (PMID: 19086372)
      Viruses. 2022 Apr 20;14(5):. (PMID: 35632594)
      Viruses. 2019 Nov 13;11(11):. (PMID: 31766215)
      Vet Rec. 1992 May 30;130(22):493-4. (PMID: 1322579)
      Avian Dis. 2021 Dec;65(4):631-636. (PMID: 35068108)
      J Virol Methods. 2006 Dec;138(1-2):60-5. (PMID: 16934878)
      Avian Pathol. 2014;43(5):406-13. (PMID: 25133705)
    • Contributed Indexing:
      Keywords: genotyping; infectious bronchitis virus; spike protein gene; variants
    • Accession Number:
      0 (Spike Glycoprotein, Coronavirus)
    • Publication Date:
      Date Created: 20240807 Date Completed: 20241025 Latest Revision: 20241103
    • Publication Date:
      20250114
    • Accession Number:
      PMC11529142
    • Accession Number:
      10.1177/10406387241265955
    • Accession Number:
      39108146